Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · IEX Real-Time Price · USD
0.960
+0.012 (1.29%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Gossamer Bio Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Gossamer Bio stock have an average target of 9.20, with a low estimate of 4.00 and a high estimate of 15. The average target predicts an increase of 858.53% from the current stock price of 0.96.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Gossamer Bio stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 2 | 3 | 3 | 3 | 3 |
| Hold | 2 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Initiates $9 | Buy | Initiates | $9 | +837.70% | Jun 25, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $8 | Strong Buy | Maintains | $8 | +733.51% | Jun 17, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +941.88% | May 20, 2024 |
| Wedbush | Wedbush | Buy Reiterates $4 | Buy | Reiterates | $4 | +316.75% | May 8, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $10 | Strong Buy | Reiterates | $10 | +941.88% | May 6, 2024 |
Financial Forecast
Revenue This Year
122.40M
Revenue Next Year
3.72M
from 122.40M
Decreased by -96.96%
EPS This Year
-0.30
from -1.18
EPS Next Year
-0.77
from -0.30
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 168.0M | 30.7M | 105.0M | 321.3M | 417.9M |
| Avg | 122.4M | 3.7M | 33.9M | 124.2M | 212.3M |
| Low | n/a | n/a | n/a | 31.5M | 124.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | -75.0% | 2,720.3% | 847.2% | 236.4% |
| Avg | - | -97.0% | 811.1% | 266.2% | 70.9% |
| Low | - | - | - | -7.0% | -0.0% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.10 | -0.59 | 0.14 | 0.68 | 1.00 |
| Avg | -0.30 | -0.77 | -0.41 | -0.11 | 0.09 |
| Low | -0.77 | -0.94 | -0.87 | -0.68 | -0.50 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.